1. Abstract 1.1. Background: Hepatoid Adenocarcinoma of the Stomach (HAS) is a unique and rare subtype of gastric cancer with poor prognosis and hepatocellular carcinoma-like features. However, the standard therapies are still in the development stage.
1. Abstract 1.1. Background and Aim: This study is to investigate the value of Diffusion Kurtosis Imaging (DKI) in predicting the recurrence and postoperative liver function deterioration of intermediate-stage hepatocellular carcinoma treated with Transarterial Chemoembolization (TACE).
1. Abstract 1.1. Background It is widely believed that liver transplantation is the only way to cure hepatic cirrhosis. However, due to limited funds and liver donors, liver transplantation is seldom performed in Asia, especially in China. For patients who have experienced oesophageal and gastric varices bleeding and waiting for a liver transplant, transjugular intrahepatic …
1. Abstract 1.1. Background: Abdominal cocoon syndrome is a rare condition that refers to total or partial encapsulation of the small intestines leading to recurrent bowel obstruction. It usually affects young ladies from tropical and subtropical area. DOI:http://dx.doi.org/10.47829/JJGH.2022.8301
1. Abstract 1.1. Background & Aims: The correlation of histological features with clinical and endoscopic data is one of the crucial steps in the accurate diagnosis of inflammatory bowel disease (IBD). This study compares the diagnostic and clinical outcomes of two cohorts of patients undergoing colonoscopy before and after the introduction of a formal biopsy …
1. Clinical Image A 62-year-old woman is presented with nausea, vomiting, abdominal pain, fever, and pale color of defecation for one week. She denied other gastrointestinal symptoms. Physical examination was unremarkable. Laboratory tests showed the following abnormal tests: SGPT: 131 U/L, SGOT: 56 U/L, ALP: 575 U/L, GGT: 911 U/L, Total bilirubin: 10,4 mg/dL, direct …
1. Abstract 1.1. Background: Nonalcoholic fatty liver disease (NAFLD), one of the most common causes of chronic liver diseases, is characterized by chronic liver inflammation and fibrosis, which consequently promote cirrhosis and liver cancer. Pemafibrate, a selective PPARα modulator is a new lipid-lowering drug that provides better hypertriglyceridemia control compared to greater other fibrates without …
1. Summary (Aim) The author proposes to test the effectiveness of the combined action of 1- Micronized Purified Flavonoid Fraction – MPFF associated with topical action “barrier effect” of 2 – Sucralfate (as SOS – Sucralfate Ointment with Soothing Herbs) for some of the most common anal pathological situations with two main objectives: DOI:http://dx.doi.org/10.47829/JJGH.2021.8202
1. Abstract Coronaviruses are important human and animal pathogens. We will show that probably antibodies don’t have essential role in immunity against COVID-19 in long term, but a type of white globules named T cells may have critical role in immunity against COVID-19. T cells have long time memory to remain in blood.
1. Abstract 1.1. Background. This study describes a case series that addresses the complex anesthetic management of adrenalectomy for patients with pheochromocytoma. It is a rare tumor, originating in the chromaffin cells of the adrenal medulla and a catecholamine-secreting agent, whose most common triad of symptoms is headache, sweating and tachycardia. DOI:http://dx.doi.org/10.47829/JJGH.2021.8201
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.